|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/17 | |
| A61K 45/00 | |||
| A61P 25/16 | |||
| A61P 25/28 | |||
| A61K 31/70 |
| (11) | Number of the document | 2249861 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09701647.1 |
| Date of filing the European patent application | 2009-01-16 | |
| (97) | Date of publication of the European application | 2010-11-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-07-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/CA2009/000074 |
| Date | 2009-01-16 |
| (87) | Number | WO 2009/089635 |
| Date | 2009-07-23 |
| (30) | Number | Date | Country code |
| 11253 | 2008-01-16 | US | |
| 11284 | 2008-01-16 | US |
| (72) |
KAY, Denis G., CA
|
| (73) |
Neurodyn Life Sciences Inc.,
Suite 508 NRC-INH 550 University Ave.,, Charlottetown, P.E.I., C1A 4P3,
CA
|
| (54) | PROGRANULIN FOR USE IN TREATING PARKINSON`S DISEASE OR ALZHEIMER`S DISEASE |
| PROGRANULIN FOR USE IN TREATING PARKINSON`S DISEASE OR ALZHEIMER`S DISEASE |